Table 1.
Demographics and baseline parameters in experiment 1
| Measurement Unit | PAD | PAD Range | Healthy | Healthy Range | P |
|---|---|---|---|---|---|
| Men/Women | 5/3 | 5/3 | |||
| Age, yr | 63 ± 2 | 51–74 | 62 ± 3 | 58–74 | 0.749 |
| Height, m | 1.67 ± 0.04 | 1.52–1.85 | 1.73 ± 0.03 | 1.60–1.83 | 0.187 |
| Weight, kg | 79.3 ± 5.3 | 59.0–102.1 | 74.8 ± 4.3 | 58.2–97.5 | 0.522 |
| Body mass index, kg/m2 | 28.5 ± 2.0 | 22.2–34.1 | 25.4 ± 0.8 | 22.7–29.1 | 0.114 |
| ABI least symptomatic | 0.83 ± 0.04* | 0.70–0.96 | 1.02 ± 0.04 | 0.91–1.24 | 0.005 |
| ABI most symptomatic | 0.60 ± 0.04* | 0.43–0.71 | 1.07 ± 0.04 | 0.92–1.23 | <0.001 |
| Systolic blood pressure, mmHg | 137 ± 8 | 109–164 | 119 ± 3 | 104–131 | 0.055 |
| Diastolic blood pressure, mmHg | 73 ± 2 | 65–80 | 75 ± 2 | 65–83 | 0.477 |
| Mean arterial pressure, mmHg | 97 ± 5 | 80–126 | 89 ± 2 | 77–96 | 0.170 |
| Heart rate, beats/min | 64 ± 4 | 49–78 | 56 ± 3 | 43–74 | 0.101 |
| ATT, mm | 5.63 ± 0.81 | 3.07–8.50 | 5.28 ± 0.51 | 3.22–6.79 | 0.719 |
| Calf circumference, cm | 33.8 ± 0.7 | 30.5–36.5 | 34.4 ± 0.3 | 33.0–35.5 | 0.564 |
| Lesion location | |||||
| Aortoiliac | 1 | ||||
| Femoropopliteal | 6 | ||||
| Infrapopliteal | 2 | ||||
| Multiple | 6 | ||||
| Medications | |||||
| Anticoagulants | 6 | ||||
| Antiaggregants | 7 | ||||
| Statins | 5 | ||||
| Antihypertensives | 8 | ||||
| β-Blockers | 3 | ||||
| Drugs labeled for PAD | 1 |
Values are means ± SE and also as min-max values.
ABI, ankle brachial index; ATT, adipose tissue thickness over medial gastrocnemius; PAD, peripheral artery disease.
*
P < 0.05 compared with healthy subjects were obtained with independent samples via t-test.